Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Rationale: Survivors of hospitalization for community-acquired pneumonia (CAP) are at increased risk of cardiovascular events, repeat infections, and death in the following months but the cause is unknown. Objectives: To investigate whether persistent inflammation, defined as elevating circulating inflammatory markers at hospital discharge, is associated with subsequent outcomes. Methods: Prospective cohort study at 28 sites. Measurements and Main Results: We used standard criteria to define CAP and the National Death Index to determine all-cause and cause-specific 1-year mortality. At hospital discharge, 1,799 subjects (77.5%) were alive and vital signs had returned to normal in 1,512 (87%) subjects. The geometric means (±SD) for circulating IL-6 and IL-10 concentrations were 6.9 (±1) pg/ml and 1.2 (±1.1) pg/ml. At 1 year, 307 (17.1%) subjects had died. Higher IL-6 and IL-10 concentrations at hospital discharge were associated with an increased risk of death, which gradually fell over time. Using Gray's survival model, the associations were independent of demographics, comorbidities, and severity of illness (for each log-unit increase, the range of adjusted hazard ratios [HRs] for IL-6 were 1.02–1.46, P < 0.0001, and for IL-10 were 1.17–1.44, P = 0.01). The ranges of HRs for each log-unit increase in IL-6 and IL-10 concentrations among subjects who did and did not develop severe sepsis were 0.95–1.27 and 1.07–1.55, respectively. High IL-6 concentrations were associated with death due to cardiovascular disease, cancer, infections, and renal failure (P = 0.008). Conclusions: Despite clinical recovery, many patients with CAP leave hospital with ongoing subclinical inflammation, which is associated with an increased risk of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence from the sepsis [30][31][32][33][34], ARDS [7,35,36], and trauma [37,38] literature suggests that degree of elevation in inflammatory cytokines (e.g., TNF, IL-1β, IL-6) on ICU admission and during ICU stay correlates with disease severity and hospital mortality, and that persistent elevation of cytokines at hospital discharge is associated with adverse long-term outcomes [39].”
From Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a multispecialty task force of the society of critical care medicine (SCCM) and the European society of intensive care medicine (ESICM) (2017) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 2×
“We ascertained comorbid conditions using the Charlson comorbidity index ( 12 ) and severity of illness using the Acute Physiology and Chronic Health Evaluation (APACHE) III and the Pneumonia Severity Index (PSI) (11, 13).”
MethodInfluentialVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Self-citationA Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360402 · Cited by 4,582 · cited 5×
“We diagnosed CAP based on clinical and radiologic criteria ( 11 ).”
BackgroundMethodInfluentialSelf-citationThe APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439 · cited 3×
“Severe sepsis occurred in a fourth of the participants and more than half had severe CAP, as indicated by a PSI class of IV or V.”
MethodInfluentialThe APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Tutorial in biostatistics: competing risks and multi‐state models
Putter, H., Fiocco, M., & Geskus, R. B. (2007) · Statistics in Medicine · doi:10.1002/sim.2712 · Cited by 2,440 · cited 1×
“For cause-specific mortality, we used Putter’s competing risk model (21) to assess associations between cytokines and cause-specific mortality, because the associations between cytokines and different causes of death are dependent and these risks compete with one another until a subject dies due to a specific cause of…”
MethodRidker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429 · cited 2×
“This association is consistent with prior studies showing increased risk of these conditions in patients with higher proinflammatory cytokines (25, 26, 29).”
BackgroundResultRisk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
Smeeth, L., Thomas, S. L., Hall, A. J., Hubbard, R., Farrington, P., & Vallance, P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041747 · Cited by 1,375
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Research works printed but not linked: 2
- 1989, Public Health Rep, 104, 350
- 2006, Proc Am Thorac Soc, 3, A274
Cited by
Mayr, F. B., Yende, S., & Angus, D. C. (2014) · Virulence · doi:10.4161/viru.27372 · Cited by 1,208
“For example, higher circulating levels of inflammatory and coagulation markers were observed at hospital discharge when patients appeared to have clinically recovered from infection and increased subsequent mortality.(76)”
BackgroundSelf-citationSepsis: a roadmap for future research
Cohen, J., Vincent, J.-L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S., Delaloye, J., Opal, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 992
Self-citationGuidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
“[415] Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis PCS 3A+”
The immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
Torres, A., Cilloniz, C., Niederman, M. S., Menéndez, R., Chalmers, J. D., Wunderink, R. G., & van der Poll, T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00259-0 · Cited by 798
Metadata
- Authors
- Yende, S., D'Angelo, G., Kellum, J. A., Weissfeld, L., Fine, J., Welch, R. D., Kong, L., Carter, M., & Angus, D. C.
- Affiliations
- University of Pittsburgh (US)
- Department of Biostatistics, Graduate School of Pubic Health, University of Pittsburgh, Pittsburgh, Pennsylvania
- Norwalk Hospital (US)
- Wayne State University (US)
- Pennsylvania State University (US)
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-01
- Volume
- 177
- Issue
- 11
- Pages
- 1242-1247
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC2720087
- OpenAlex
- W2034443456
- Cited by
- 434
- References
- 30
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 18 · 2023: 19 · 2022: 21 · 2021: 35 · 2020: 30 · 2019: 29 · 2018: 29 · 2017: 26 · 2016: 29 · 2015: 32 · 2014: 28 · 2013: 17 · 2012: 17
- FWCI
- 17.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline (R01 GM61992)
- National Institute of General Medical Sciences (R01GM061992)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- community-acquired pneumonia, sepsis, inflammatory markers, interleukin-6, IL-10, chronic inflammation, post-discharge mortality, cardiovascular mortality, all-cause mortality, subclinical inflammation
- MeSH terms
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Patient Discharge, Pneumonia, Predictive Value of Tests, Cohort Studies, Interleukin-6, Survival Rate, Interleukin-10, Treatment Outcome, Community-Acquired Infections, Sepsis, Recovery of Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis. https://app.cochat.ai/papers/10.1164/rccm.200712-1777oc
- The paper
- Yende, S., D'Angelo, G., Kellum, J. A., Weissfeld, L., Fine, J., Welch, R. D., Kong, L., Carter, M., & Angus, D. C. (2008). Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200712-1777oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.